ORPHENADRINE CITRATE — all Canadian products
7 DINs
1 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is ORPHENADRINE CITRATE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02243559 | SANDOZ ORPHENADRINE | SANDOZ CANADA INCORPORATED | Tablet (Extended-Release) | Oral | ORPHENADRINE CITRATE 100 MG | Marketed | |
| 01966154 | NORFLEX | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Tablet (Extended-Release) | Oral | ORPHENADRINE CITRATE 100 MG | Cancelled Post Market | |
| 01966162 | NORFLEX | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Liquid | Intravenous; Intramuscular | ORPHENADRINE CITRATE 30 MG | Cancelled Post Market | |
| 01966189 | NORGESIC FORTE TAB | 3M PHARMACEUTICALS, A DIVISION OF 3M CANADA COMPANY | Tablet | Oral | ORPHENADRINE CITRATE 50 MG; ACETYLSALICYLIC ACID 770 MG; CAFFEINE 60 MG | Cancelled Post Market | |
| 01966170 | NORGESIC TAB | 3M PHARMACEUTICALS, A DIVISION OF 3M CANADA COMPANY | Tablet | Oral | ORPHENADRINE CITRATE 25 MG; ACETYLSALICYLIC ACID 385 MG; CAFFEINE 30 MG | Cancelled Post Market | |
| 02047535 | ORFENACE TABLET 100MG | STERIMAX INC | Tablet | Oral | ORPHENADRINE CITRATE 100 MG | Dormant | |
| 02229731 | ORPHENADRINE CITRATE INJECTION, USP | STERIMAX INC | Liquid | Intravenous; Intramuscular | ORPHENADRINE CITRATE 30 MG | Dormant |
Browse other molecules: